Carver Biosciences
Latest round
- Seed
Last raised
- Sep 2021
Total raised
- $3M
Investors
- 1
About Carver Biosciences
Based in Massachusetts, US, and founded in 2021 by Walter R. Strapps (CEO), and Cameron Myhrvold (Assistant Professor), Carver Biosciences operates as a healthcare company that offers solutions for treating different viruses that affect humans. Carver Biosciences created Cas13-based technology to treat patients infected with respiratory viruses. This technology provides a programmable platform for treating various existing viruses as well as quickly responding to new viruses as they emerge.
Who invested in Carver Biosciences
1 investor across 1 round
See all investors in Carver Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 15, 2021
Amount
$3M
Investors
Questions about Carver Biosciences
Who invested in Carver Biosciences?
Carver Biosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Carver Biosciences raised?
Carver Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Carver Biosciences last raise money?
Carver Biosciences's most recent round on record is a Seed, in Sep 2021.
What does Carver Biosciences do?
Based in Massachusetts, US, and founded in 2021 by Walter R.
Where is Carver Biosciences headquartered?
Carver Biosciences is headquartered in Boston, US.
Which VCs invest in companies like Carver Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Carver Biosciences's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Carver Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.